Literature DB >> 12458351

Laboratory diagnosis of influenza--virology or serology?

R Allwinn1, W Preiser, H Rabenau, S Buxbaum, M Stürmer, H W Doerr.   

Abstract

Although classical influenza is a clinically typical illness ("unchanging disease due to a changing agent"), laboratory investigations are essential at the beginning of each influenza epidemic. They should confirm suspected influenza cases and exclude "flu-like illnesses" which may be caused by numerous other viral and bacterial agents. Different virological as well as serological methods are available. For early diagnosis of acute influenza virus infections, virus detection using rapid procedures for virus isolation or antigen staining and molecular biological techniques have been developed. The determination of specific antibodies (IgG, IgM) has traditionally been widely used diagnostically. Conventional serological diagnosis is possible by means of the complement fixation and hemagglutination inhibition tests and allows the detection of type- and subtype-specific antibodies, respectively. As part of an automated serology, immunofluorescence test and enzyme-linked immunosorbent assay are the mostly widely available methods. In comparison, virus detection is clearly superior to antibody determination for diagnosis of influenza virus infections. However, antibody testing may be useful as a complementary tool to confirm the diagnosis retrospectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458351     DOI: 10.1007/s00430-002-0137-y

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  13 in total

Review 1.  Recent publications in medical microbiology and immunology: a retrospective.

Authors:  H W Doerr; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

2.  Use of semiconductor-based oligonucleotide microarrays for influenza a virus subtype identification and sequencing.

Authors:  Michael J Lodes; Dominic Suciu; Mark Elliott; Axel G Stover; Marty Ross; Marcelo Caraballo; Kim Dix; James Crye; Richard J Webby; Wanda J Lyon; David L Danley; Andrew McShea
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

Authors:  Regina Allwinn; Janina Geiler; Annemarie Berger; J Cinatl; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2010-02-17       Impact factor: 3.402

Review 4.  An influenza A H1N1 virus revival - pandemic H1N1/09 virus.

Authors:  M Michaelis; H W Doerr; J Cinatl
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553

5.  Rapid method for detection of influenza a and B virus antigens by use of a two-photon excitation assay technique and dry-chemistry reagents.

Authors:  Janne O Koskinen; Raija Vainionpää; Niko J Meltola; Jori Soukka; Pekka E Hänninen; Aleksi E Soini
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

Review 6.  Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.

Authors:  Martin Michaelis; Hans Wilhem Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-06-20       Impact factor: 3.402

7.  Seroprevalence of influenza A and B in German infants and adolescents.

Authors:  Andreas Sauerbrei; R Schmidt-Ott; H Hoyer; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2009-02-05       Impact factor: 3.402

8.  Optimal design of intervention studies to prevent influenza in healthy cohorts.

Authors:  Brendan Klick; Hiroshi Nishiura; Benjamin J Cowling
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  Identification of upper respiratory tract pathogens using electrochemical detection on an oligonucleotide microarray.

Authors:  Michael J Lodes; Dominic Suciu; Jodi L Wilmoth; Marty Ross; Sandra Munro; Kim Dix; Karen Bernards; Axel G Stöver; Miguel Quintana; Naomi Iihoshi; Wanda J Lyon; David L Danley; Andrew McShea
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

10.  Primer development to obtain complete coding sequence of HA and NA genes of influenza A/H3N2 virus.

Authors:  Agustiningsih Agustiningsih; Hidayat Trimarsanto; Vivi Setiawaty; I Made Artika; David Handojo Muljono
Journal:  BMC Res Notes       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.